Pathological Diagnosis of Barrett’s Esophagus

Slides:



Advertisements
Similar presentations
Assessment Module Layout
Advertisements

Luigi Bonavina,MD Cattedra e U.O. Chirurgia Generale, Policlinico San Donato Università degli Studi di Milano XXIV Congresso Nazionale A.C.O.I. Montecatini.
Management of Barrett ’ s Esophagus Joint Hospital Surgical Grand Ground 17 th July 2010 Dr KS Chan Queen Elizabeth Hospital.
Ferrara 27 Settembre 2014 Camera di Commercio, Largo Castello
Laparoscopic Fundoplication and Barrett’s Carlos A. Pellegrini University of Washington Seattle, WA GI Cancer Course Saint Louis University.
GENERAL THORACIC SURGERY CHAPTER 141
Esophagus Anatomy, Physiology, and Diseases
Advanced Endoscopy Techniques
Barrett’s Esophagus Stuart Jon Spechler, M.D. Chief of Gastroenterology, Dallas VA Medical Center; Professor of Medicine, Berta M. and Cecil O. Patterson.
Joint Hospital Surgical Grand Round 19 June 2004.
Intestinal Metaplasia of the Stomach
Ca Cardia “Out of the Black Box” Dr Daniel Ng NDH / AHNH Dr Daniel Ng NDH / AHNH.
Paraesophageal Hiatal Hernias Bradley J. Phillips, MD Burn-Trauma-ICU Adults & Pediatrics.
Esophagus: Normal Lower Esophageal and Squamo- columnar Junction Mucosae.
Histology of the upper Git
Gastroesophageal Reflux Disease (GERD)
Gastroenterology Grand Rounds February 20, 2014 Fellow: David Tang, M.D. Faculty: Marcelo Vela, M.D.
 Risk factors: hiatal hernia, duodenogastric  reflux,delayed acid clearance time, ↓LESp  Adult disorder → 376 per  Irreversible condition 
The ulcer of gastric stump: a case-control study Coordinators: Author: Roxana Spac Dr.Anca Negovan Drd. Monica Pantea Co-author: Dr Nina Sincu Andreea.
Esophagus cancer Dr Sanei Associated professor of pathology GI and Liver patholoogist.
Evaluation Of Colonic Polyps Kathia E. Rosado Orozco MD GI and Liver Pathologist Hato Rey Pathology Associates.
Liam Murray Cancer Epidemiology and Prevention Research Group Queen’s University Belfast Dublin September 3 rd 2009 The Northern Ireland Barrett’s Register:

The Role of Secondary Versus Tertiary Prevention in Decreasing the Incidence of Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus Lindsay.
HISTOLOGY OF ESOPHAGUS &gastro esophageal junction
Gastrointestinal system SYLLABUS: RBP(Robbins Basic Pathology) Chapter: The Oral Cavity and the Gastrointestinal Tract.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Prof KHALED HEMIDA Ain Shams University. قال الله تعالي : يرفع الله الذين آمنوا منكم و الذين أوتوا العلم درجات. قال رسول الله ( صلي الله عليه و سلم ):
GI conference Case 3 Stomach and liver F/69 S
Eradication of Helicobacter pylori After Endoscopic Resection of Gastric Tumors Does Not Reduce Incidence of Metachronous Gastric Carcinoma Clinical Gastroenterology.
Classification of superficial neoplastic lesion : stomach 소 화 기 내 과 황보 영.
Barrett Esophagus 2008 년도 2 학기 의학과 석. 박사 공통과목 위장관의 외과병리.
Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett’s Esophagus Ganapathy A. Prasad, M.D. Navtej S. Buttar,
Normal stomach. Fundic mucosa with parietal & chief cells Antral mucosa with mucin secreting glands Stomach - Histology.
Minesh Mehta, PGY-4 University of Louisville Department of Gastroenterology BARRETT’S ESOPHAGUS.
Gastrointestinal pathology esophagus and stomach lecture 2
GI For Rehabilitation.
The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus The Prague C & M Criteria Gastroenterology 2006;131:1392~1399 This.
Controversies in Barrett Esophagus
Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region  Tsung-Teh Wu, Toshiaki Watanabe, Richard.
The Prevalence of and Risk Factors for Barrett Esophagus in a Korean Population - A Nationwide Multicenter Prospective Study - J Clin Gastroenterol 2009.
Management of Gastric Polyps: An Endoscopy-Based Approach
GI Pathology Lab Dr Heyam.
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Barrett’s Esophagus: Does that Z-line look irregular to you?
Volume 120, Issue 7, Pages (June 2001)
(A) Region of esophagus demonstrating Barrett esophagus: The normal squamous epithelium (left margin of figure) is replaced by specialized columnar epithelium.
An Unusual Presentation of Esophageal Cancer: A Case Report and Review of Literature. Abraham Yacoub M.D.1, Regina Frants, M.D., F.A.C.P.2, Leslie Bank,
Contribution by: Prof. Dr. J.J. Kolkman
Volume 134, Issue 4, Pages (April 2008)
Preinvasive Neoplasia in the Stomach: Diagnosis and Treatment
Management of Gastric Polyps: An Endoscopy-Based Approach
Surveillance of Dysplasia in Inflammatory Bowel Disease: The Gastroenterologist- Pathologist Partnership  David T. Rubin, Jerrold R. Turner  Clinical Gastroenterology.
Carcinogenesis of Helicobacter pylori
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Volume 120, Issue 7, Pages (June 2001)
Volume 145, Issue 4, Pages (October 2013)
Volume 136, Issue 4, Pages (April 2009)
Review on Management of Gastro-esophageal Junction Cancer
Elizabeth Montgomery, Marcia Irene Canto 
Gastrointestinal Pathology I
The diagnosis of Barrett's esophagus: goblets, goblets, goblets
Volume 117, Issue 1, Pages (July 1999)
Marcia Irene Canto, MD, MHS  Gastrointestinal Endoscopy 
Volume 123, Issue 1, Pages (July 2002)
GERD and Peptic ulcer Lab
In Vivo Diagnosis and Classification of Colorectal Neoplasia by Chromoendoscopy- Guided Confocal Laser Endomicroscopy  Silvia Sanduleanu, Ann Driessen,
Controversies in Barrett Esophagus
Presentation transcript:

Pathological Diagnosis of Barrett’s Esophagus MEE-YON CHO, M.D.,PD. Department of Pathology Wonju College of Medicine, Yonsei University

History of BE Norman Barrett : congenital origin and a part of stomach (1950) Allison and Johnstone (1953) : esophagus lined with gastric mucous membrane Moersch : inflammtory metaplasia (1959) Bremner : association between columnar-lined esophagus and GERD (1970) Intestinal metaplasia is a premalignant lesion for adenocarcinoma of esophagus

Definition of Barrett’s Esophagus Columnar-lined esophagus (Naef AP. J Thorac Cardiovasc Surg 1975) 3 cm of columnar lining or intestinal metaplasia (Spechler SJ. N Engl J Med 1992) Intestinal metaplasia in the esophagus without specification of length (Sampliner RE Am J Gastroenterol 1998) Short-segment of Barrett’s esophagus ; <3 cm in length (Johnston MH, Weston AP. Am J Gastroenterol 1996)

Barrett’s Esophagus Definition: 2-Fold Endoscopically visible columnar epithelium in the esophagus which, on biopsy, has: Metaplastic columnar epithelium, defined by acid-mucin containing goblet cells From Sampliner RE. ACG Practice guidelines. Am J Gastroenterol 1998;93:1028

Questions in the Histologic DX of Barrett’s Esophagus Is it Barrett’s esophagus or gastric cardia ? : Endoscopic description of columnar-lined esophagus. How much metaplastic epithelium is needed to diagnose Barrett’s?

Definitional Problems in Barrett’s Esophagus Endoscopic and histologic components both required : Three anatomic landmarks must be separately identified and biopsied a. Gastroesophageal junction (GEJ) b. Proximally displaced squamocolumanr junction (SCJ) or Z-line c. Intervening pink mucosa in tubular esophagus of possible Barrett’s epithelium 3. Barrett’s esophagus (vs) intestinal metaplasia in gastric cardia

Anatomic landmarks of Distal esophagus and proximal stomach : A. normal and H. pylori carditis B. GERD induced columnar metaplasia (Am J Gastroenterol 2005;100:1853-1867)

Endoscopic picture of the longitudinal submucosal vessels characteristic for the distal esophagus

Oxyntic (fundic) type Cardiac type Oxyntocardiac type Intestinal type

Epithelial types at the gastroesophageal junctional region Am J Surg Pathol 2000 March;24(3):344-351

Gastric Cardia Chandrasoma (2000) : CM is abscent in 70% of autopsy Hayward (1961) : Cardiac mucosa (CM) lined the distal 2cm of the tubular esophagus and extended into the proximal stomach Chandrasoma (2000) : CM is abscent in 70% of autopsy Kilgore (2000) : CM in all pediatric autopsy (0.1~0.4cm) Glickman (2002) : abscence of CM in 19% of symptomatic pediatric patient

Summary of Studies Designed to Evaluate Cardia Mucosa Author Type of specimen Study population Mucous glands Mixed glands Oxyntic glands Mean Length Glickman Biopsy (n=74) 0.1-18yr (median 13yr) 81% 19% 0% <1.0mm Kilgore Autopsy (n=30) 16days-18yr (median 6.3yr) 100% 1.8mm Derdoy Autopsy (n=100 1day-18yr (median 2.2yr) 1.0mm Park Autopsy (n=23) Prenatal;18-34wk, postnatal; 9days-15yr <0.4mm Marsman Biopsy (n=198) 21-87yr (mean 50yr) 62% 38% Sarbia Resection (n=36) Adult Entire 56% Partial 97% 61% Mucous gl:1-15mm, mixed gl:1-24mm Chandrasoma Autopsy (n=9) Mainly adult 80%>20yr 19/72 8/18 32/72 18/18 21/72 9/18 Zhou Autopsy (n=77) Prenatal (15-39wk) Postnatal (40wk-17yr) 5% 48% 55% 46% 6% (Am J Gastroenterol 2005;100:1853-1867)

A summary of the pH data (expressed as percent time pH<4) in 53 patients classified as three groups. (Am J Surg Pathol 2000;24:344-351)

Patient population classified according to the percentage of patients with oxyntic mucosa only, oxyntocardiac mucosa, cardiac mucosa, and intestinal metaplasia : groups 1 to 4 based on length of abnormal columnar epithelium. (American Journal of Surgical Pathology 2003; 27(7):929-936).

Reflux-Adenocarcinoma Sequence P Chandrasoma. (Histopathology 2005;46:361-373)

Problems in defining Barrett’s esophagus by intestinal metaplasia (IM) and goblet cells Sampling effect related to patchy distribution of goblet cells False positive diagnosis of BE : IM of gastric cardia

A Critical Review of the Diagnosis and Management of Barrett’s Esophagus : The AGA Chicago Workshop Esophageal IM (intestinal metaplasia) documented by histology is a prerequisite criterion for the diagnosis of BE Special stains (A. blue, PAS and others) are necessary for the histologic diagnosis of BE Markers such as cytokeratin staining distinguish IM of esophagus from IM of stomach The working definition of BE is displacement of the SCJ proximal to the GEJ with the presence of IM Endoscopy with multiple systemic biopsies is needed to establish the diagnosis of BE The normal appearing and normally located SCJ should not be biopsied A patient with columanr-lined distal esophagus without confirmed IM on biopsy requires a follow-up endoscopy The use of flow cytometry or biomarkers (p16 and p53) is promising and merits further clinical research (Gastroenterology 2004;127:310-330)

A Critical Review of the Diagnosis and Management of Barrett’s Esophagus : (The AGA Chicago Workshop) Esophageal IM (intestinal metaplasia) documented by histology is a prerequisite criterion for the diagnosis of BE (evidence linking IM to esophageal carcinoma) : IM and dysplasia both adjascent to and remote from adenocarcinoma : Dysplasia arising in cardiac-type or fundic type mucosa – uncommon : Neoplastic risk of cardiac- and fundic-type mucosa is not known (Subgroup support C, Group grading accept 88%)

A Critical Review of the Diagnosis and Management of Barrett’s Esophagus : The AGA Chicago Workshop 2. Special stains (A. blue, PAS and others) are necessary for the histologic diagnosis of BE : not required routinely : In select cases, to avoid overinterpretation of pseudogoblet cells (Subgroup support D, Group grading accept 6%)

Pseudogoblet cells

A B AB positive cells Normal gastric mucous neck cells Reactive surface (foveolar) cells Columnar epithelium in duct of submucosal gland C

A Critical Review of the Diagnosis and Management of Barrett’s Esophagus : The AGA Chicago Workshop 3. Markers such as cytokeratin staining distinguish IM of esophagus from IM of stomach : Superficial and deep CK 7 + and superficial CK20 + (so-called “Barrett’s CK7/20 pattern”) : Controversial (Subgroup support D, Group grading accept 50%)

A Critical Review of the Diagnosis and Management of Barrett’s Esophagus : The AGA Chicago Workshop 4. The working definition of BE is displacement of the SCJ proximal to the GEJ with the presence of IM : Majority agreed that the proposed definition is practical. (A few : endoscopic recognition of CLE may be sufficient for the diagnosis of BE) : Identification of endoscopic landmarks was moderately reproducible : good consensus (Subgroup support B, Group grading accept 89%)

A Critical Review of the Diagnosis and Management of Barrett’s Esophagus : The AGA Chicago Workshop 5. Endoscopy with multiple systemic biopsies is needed to establish the diagnosis of BE : IM is not uniformly distributed :>20% of long-segment CLE may not have IM on a single set biopsy : 4-quadrant biopsy protocol every 2cm. (Subgroup support A, Group grading accept 100%)

Biopsy Protocol

Endoscopic picture of the longitudinal submucosal vessels characteristic for the distal esophagus

A Critical Review of the Diagnosis and Management of Barrett’s Esophagus : The AGA Chicago Workshop 6. The normal appearing and normally located SCJ should not be biopsied : It is unrelated to reflux symptoms : The prevalence of cardia IM (>15%) is much higher than BE, but cardia adenocarcinoma is less common than esophageal adenocarcinoma (Subgroup support C, Group grading accept 99%)

Intestinal metaplasia at the GEJ Incidence : 11~36% (18%) IM No IM Significance Reflux Sx 38% 44% NS Endoscopic esophagitis 10% 14% Age 61 (29-90) 51 (22-83) P<0.01 Antral IM 24% 6% P=0.04 H. pylori 57% 41% Gut 1997;41:585-589, Mod Pathol 2000;13:614-20.

Intestinal metaplasia at the EGJ Incidence : 11.5% in 215 Korean pt. IM No IM Significance Reflux Sx 37.5% 34.6% NS Endoscopic esophagitis 45.9% 17.1% P <0.05 Age 56.2 39.8 P<0.05 Antral IM 45.8% 17.3% H. pylori 75.0% 65.7% Korean J Gastroenterol 2002;40:15-22

Table. Prevalence of Intestinal Metaplasia at the GEJ on Histological Examination of Biopsy Material of Patients Without Endoscopically Apparent BE.

GERD clinical profile + - Irregular Z-line + - Esophagitis + - Summary of Features that help Differentiate Intestinal Metaplasia (IM) in the Distal Esophagus (DE) from the Gastric Cardia (GC) Feature IM in DE IM in GC GERD clinical profile + - Irregular Z-line + - Esophagitis + - Gastritis - + H pylori - + Eosinophils ++ + Neut, Plasma,Lymph + ++ Multilayered epithelium + - HID stain positive + - MUC 1,6 positive + - BE CK7/20 pattern + ± Complete>incomplete IM - + (Am J Gastroenterol 2005;100:1853-1867)

Proposed classification of intestinal metaplasia Terminology Length Adenocarcinoma risk Surveillance recommended LSBE ≥ 3cm Yes SSBE < 3cm Gastric cardia IM Unclear No (Am J Gastroenterol 1998;93:1033-6)

A Critical Review of the Diagnosis and Management of Barrett’s Esophagus : The AGA Chicago Workshop 7. A patient with columanr-lined distal esophagus without confirmed IM on biopsy requires a follow-up endoscopy : due to sampling error or interim development of IM : should consider systemic biopsies (Subgroup support C, Group grading accept 72 %)

A Critical Review of the Diagnosis and Management of Barrett’s Esophagus : The AGA Chicago Workshop 8. The use of flow cytometry or biomarkers (p16 and p53) is promising and merits further clinical research : Flow cytometry identified low- and high-risk subset with 0% and 28% 5-year cumulative incidence of cancer : p53 mutation and LOH : p16 methylation, mutation and LOH (Subgroup support A, Group grading accept 88%)

Diagnosis of Columnar-lined esophagus (CLE) without Intestinal metaplasia Columnar lined esophagus with cardiac mucosa = Columnar epithelium of cardiac type Columnar lined esophagus with Oxyntocardiac mucosa = Columnar epithelium of oxyntocardiac type Columnar lined esophagus with oxyntic (fundic) mucosa = Columnar epithelium of oxyntic (fundic) type

No endoscopic information (GEJ) & No intestinal metaplaisa Columnar epithelium of cardiac type Columnar epithelium of oxyntocardiac type Columnar epithelium of oxyntic (fundic) type

Metaplastic goblet cells = Barrett’s esophagus ? Endoscopically CLE : “Columnar-lined esophagus with intestinal metaplasia c/w Barrett’s esophagus” GEJ : “Carditis with intestinal metaplasia” No information : “Goblet cell containing mucosa, either Barrett’s esophagus or carditis with intestinal metaplasia”